Abstract
Despite significant advances in stem cell manipulation and post-transplant immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major long-term morbidity in survivors of allogeneic stem cell transplantation. Extracorporeal photopheresis (ECP) is a novel therapeutic intervention which has demonstrated efficacy in patients with refractory acute and chronic GVHD. Clinical responses have been reported in skin and visceral GVHD. While the long-term immunomodulatory effects of ECP in cGVHD are unknown, recent studies of patients undergoing a 6- to 12-month course of ECP treatment demonstrated an attenuation of Th1-mediated cytokine secretion by activated T-helper cells, a shift in the DC1/DC2 ratio favoring plasmacytoid rather than monocytoid dendritic cell profiles, and a decrease in antigen responsiveness by dendritic cells. The implications of these immunomodulatory effects of ECP on pathogenesis and clinical outcome remains a fertile area for future research.
Similar content being viewed by others
References
Remberger M, Ringden O, Blau IW et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors Blood 2001 98: 1739 1745
Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 51: 443 447
Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1997 90: 4705 4709
Gaziev D, Polchi P, Galimberti M et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors Transplantation 1997 63: 854 860
Lazarus HM, Rowe JM . New and experimental therapies for treating graft-versus-host disease Blood Rev 1995 9: 117 133
Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT Haematologica 1997 82: 683 689
Ratanatharathorn V, Ayash L, Lazarus HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy Bone Marrow Transplant 2001 28: 121 129
Vogelsang GB . How I treat chronic graft-versus-host disease Blood 2001 97: 1196 1201
Shulman HM, Sale GE, Lerner KG et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 1978 91: 545 570
Eppinger T, Ehninger G, Steinert M et al. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease Transplantation 1990 50: 807 811
Aubin F, Brion A, Deconinck E et al. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients Transplantation 1995 59: 151 155
Jampel RM, Farmer ER, Vogelsang GB et al. PUVA therapy for chronic cutaneous graft-vs-host disease Arch Dermatol 1991 127: 1673 1678
Vogelsang GB, Wolff D, Altomonte V et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA) Bone Marrow Transplant 1996 17: 1061 1067
Basara N, Gunzelmann S, Willenbacher W et al. New immunosuppressants in BMT/GVHD Transplant Proc 2001 33: 2220 2222
Simpson D . Drug therapy for acute graft-versus-host disease prophylaxis J Hematother Stem Cell Res 2000 9: 317 325
Przepiorka D, Kernan NA, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 2000 95: 83 89
Vogelsang GB, Farmer ER, Hess AD et al. Thalidomide for the treatment of chronic graft-versus-host disease New Engl J Med 1992 326: 1055 1058
Bladon J, Taylor PC . Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients Br J Haematol 1999 107: 707 711
Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results New Engl J Med 1987 316: 297 303
Lim HW, Edelson RL . Photopheresis for the treatment of cutaneous T-cell lymphoma Hematol Oncol Clin North Am 1995 9: 1117 1126
Wolfe JT, Lessin SR, Singh AH, Rook AH . Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection Artif Organs 1994 18: 888 897
Rook AH, Wolfe JT . Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection J Clin Apheresis 1994 9: 28 30
Rook AH, Suchin KR, Kao DM et al. Photopheresis: clinical applications and mechanism of action J Invest Dermatol Symp Proc 1999 4: 85 90
Rook AH, Freundlich B, Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial Arch Dermatol 1992 128: 337 346
Malawista SE, Trock D, Edelson RL . Photopheresis for rheumatoid arthritis Ann NY Acad Sci 1991 636: 217 226
Barr ML, Meiser BM, Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group New Engl J Med 1998 339: 1744 1751
Wieland M, Thiede VL, Strauss RG et al. Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy J Clin Apheresis 1994 9: 171 175
Wolfe JT, Tomaszewski JE, Grossman RA et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature J Clin Apheresis 1996 11: 36 41
Ullrich SE . Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers J Invest Dermatol 1991 96: 303 308
Girardi M, Herreid P, Tigelaar RE . Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes J Invest Dermatol 1995 104: 177 182
Marks DI, Iannoni B, Coote MA et al. Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD mice by syngeneic splenocytes treated with cytotoxic drugs Autoimmunity 1991 11: 73 79
Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action J Invest Dermatol 1996 107: 235 242
Tambur AR, Ortegel JW, Morales A et al. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis Transplant Proc 2000 32: 747 748
Zouboulis CC, Schmuth M, Doepfmer S et al. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes Dermatology 1998 196: 305 308
Di Renzo M, Rubegni P, De Aloe G et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma Immunology 1997 92: 99 103
Vowels BR, Cassin M, Boufal MH et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis J Invest Dermatol 1992 98: 686 692
Berger CL, Xu AL, Hanlon D et al. Induction of human tumor-loaded dendritic cells Int J Cancer 2001 91: 438 447
Edelson RL . Photopheresis: a clinically relevant immunobiologic response modifier Ann NY Acad Sci 1991 636: 154 164
Owsianowski M, Gollnick H, Siegert W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplant 1994 14: 845 848
Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease Transplantation 1995 59: 149 151
Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Bone Marrow Transplant 1996 18: (Suppl. 2) 175 181
Dall'Amico R, Rossetti F, Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease Br J Haematol 1997 97: 848 854
Abhyankar S, Godder K, Chiang K et al. Extracorporeal photopheresis with UVADEX for the treatment of chronic graft-versus-host disease Exp Hematol 1998 26: 32
Child FJ, Ratnavel R, Watkins P et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD) Bone Marrow Transplant 1999 23: 881 887
Greinix HT, Volc-Platzer B, Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease Blood 1998 92: 3098 3104
Greinix HT, Volc-Platzer B, Kalhs P et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 2000 96: 2426 2431
Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease J Exp Med 1992 175: 405 413
Abhyankar S, Gilliland DG, Ferrara JL . Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft-versus-host disease to minor histocompatibility antigens Transplantation 1993 56: 1518 1523
Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease Bone Marrow Transplant 1997 19: 571 576
Fowler DH, Gress RE . Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma Leuk Lymphoma 2000 38: 221 234
Lu Y, Sakamaki S, Kuroda H et al. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603 Blood 2001 97: 1123 1130
Ferrara JL . Cytokine dysregulation as a mechanism of graft-versus-host disease Curr Opin Immunol 1993 5: 794 799
Korholz D, Kunst D, Hempel L et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 691 695
Alcindor T, Gorgun G, Miller KB et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease Blood 2001 98: 1622 1625
Vink AA, Moodycliffe AM, Shreedhar V et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photo-repair of cyclobutane pyrimidine dimers Proc Natl Acad Sci USA 1997 94: 5255 5260
Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells Science 1999 285: 412 415
Ramsdell F, Seaman MS, Miller RE et al. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death Int Immunol 1994 6: 1545 1553
Chan G, Foss F, Roberts T et al. Decreased acute and chronic GVHD and early full donor engrafment following a pentostatin-based preparative regimen for allogeneic bone marrow transplant in high risk patients Blood 2000 98: 383a
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foss, F., Gorgun, G. & Miller, K. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 29, 719–725 (2002). https://doi.org/10.1038/sj.bmt.1703529
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703529
- Springer Nature Limited
Keywords
This article is cited by
-
Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients
Journal of Translational Medicine (2022)
-
Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease
Bone Marrow Transplantation (2022)
-
Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD
Bone Marrow Transplantation (2014)
-
Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient
Bone Marrow Transplantation (2011)
-
Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment
Bone Marrow Transplantation (2011)